Jump to main content

yr 〜
yr

Search results 8

Mechanisms of preferential bone formation in myeloma bone lesions by proteasome inhibitors

Mechanisms of preferential bone formation in myeloma bone lesions by proteasome inhibitors
Digital博士論文障害者向け資料あり
Nakaue, Emiko, Teramachi, Jumpei, Tenshin, Hirofumi, Hiasa, Masahiro, Harada, Takeshi, Oda, Asuka, Inoue, Yusuke, Shimizu, So, Higa, Yoshiki, Sogabe, Kimiko, Oura, Masahiro, Hara, Tomoyo, Sumitani, Ryohei, Maruhashi, Tomoko, Yamagami, Hiroki, Endo, Itsuro, Tanaka, Eiji, Abe, MasahiroSpringer Nature2023-04-11
National Diet Library
  • Subject HeadingOsteoblast Osteoclast Proteasome inhibitor Pulsatile treatment Multiple ...
  • Note (General)Proteasome inhibitors (PIs) can preferentially res...

Synergistic targeting of Sp1, a critical transcription factor for myeloma cell growth and survival, by panobinostat and proteasome inhibitors 7 48

Synergistic targeting of Sp1, a critical transcription factor for myeloma cell growth and survival, by panobinostat and proteasome inhibitors 7 48
Digital博士論文障害者向け資料あり
Bat-Erdene, Ariunzaya, Miki, Hirokazu, Oda, Asuko, Nakamura, Shingen, Teramachi, Jumpei, Amachi, Ryota, Tenshin, Hirofumi, Hiasa, Masahiro, Iwasa, Masami, Harada, Takeshi, Fujii, Shiroh, Sogabe, Kimiko, Kagawa, Kumiko, Yoshida, Sumiko, Endo, Itsuro, Aihara, Kenichi, Abe, MasahiroImpact Journals2016-10-12Oncotarget
National Diet Library
  • Subject Headingmultiple myeloma panobinostat proteasome inhibitors caspase-8 Sp1
  • Note (General)...ation with the proteasome inhibitor bortezomib. Be......synergism with proteasome inhibitors. Although the......nobinostat and proteasome inhibitors in combination.

Unique anti-myeloma activity by thiazolidine-2,4-dione compounds with Pim inhibiting activity 180 2

Unique anti-myeloma activity by thiazolidine-2,4-dione compounds with Pim inhibiting activity 180 2
Digital博士論文障害者向け資料あり
Fujii, Shiro, Nakamura, Shingen, Oda, Asuka, Miki, Hirokazu, Tenshin, Hirofumi, Teramachi, Jumpei, Hiasa, Masahiro, Bat-Erdene, Ariunzaya, Maeda, Yusaku, Oura, Masahiro, Takahashi, Mamiko, Iwasa, Masami, Endo, Itsuro, Yoshida, Sumiko, Aihara, Ken-ichi, Kurahashi, Kiyoe, Harada, Takeshi, Kagawa, Kumiko, Nakao, Michiyasu, Sano, Shigeki, Abe, MasahiroWiley2018-01-12British Journal of Haematology
National Diet Library
  • Subject Heading...stance protein proteasome inhibitor BCRP
  • Note (General)...sistently, the proteasome inhibitors bortezomib an......mbination with proteasome inhibitors is envisioned.

Mechanisms of preferential bone formation in myeloma bone lesions by proteasome inhibitors

Mechanisms of preferential bone formation in myeloma bone lesions by proteasome inhibitors
Digital博士論文
中上, 絵美子, 寺町, 順平, 天眞, 寛文, 日浅, 雅博, 原田, 武志, オダ, アスカ, イノウエ, ユウスケ, 清水, 宗, ヒガ, ヨシキ, 曽我部, 公子, 大浦, 雅博, 原, 倫世, 住谷, 龍平, マルハシ, トモコ, 山上, 紘規, 遠藤, 逸朗, 田中, 栄二, 安倍, 正博Springer Nature2023-04-11International Journal of Hematology118 1p.88-98
Available onlineOther Libraries in Japan
  • Summary, etc.Proteasome inhibitors (PIs) can preferentially res...
  • Subject HeadingOsteoblast Osteoclast Proteasome inhibitor Pulsatile treatment Multiple ...

Acute accumulation of PIM2 and NRF2 and recovery of β5 subunit activity mitigate multiple myeloma cell susceptibility to proteasome inhibitors

Acute accumulation of PIM2 and NRF2 and recovery of β5 subunit activity mitigate multiple myeloma cell susceptibility to proteasome inhibitors
Digital博士論文
曽我部, 公子, 中村, 信元, 比嘉, 佳基, 三木, 浩和, オダ, アスカ, マルハシ, トモコ, 住谷, 龍平, 大浦, 雅博, タカハシ, マミコ, ナカムラ, マサフミ, マエダ, ユウサク, 原, 倫世, 山上, 紘規, 藤井, 志朗, 賀川, 久美子, 尾崎, 修治, 倉橋, 清衛, 遠藤, 逸朗, 粟飯原, 賢一, 中上, 絵美子, 日浅, 雅博, 寺町, 順平, 原田, 武志, 安倍, 正博Springer Nature2024-01-21International Journal of Hematology119 3p.303-315
Available onlineOther Libraries in Japan
  • Summary, etc.Resistance to proteasome inhibitors (PIs) has emerged as an impo...
  • Subject HeadingMultiple myeloma Proteasome inhibitor β5 subunit activity PIM2 NRF2
  • Alternative Title... resistance to proteasome inhibitors

Synergistic targeting of Sp1, a critical transcription factor for myeloma cell growth and survival, by panobinostat and proteasome inhibitors

Synergistic targeting of Sp1, a critical transcription factor for myeloma cell growth and survival, by panobinostat and proteasome inhibitors
Digital博士論文
バット エルデネ, アリウンザヤ, 三木, 浩和, オダ, アスコ, 中村, 信元, 寺町, 順平, 天知, 良太, 天眞, 寛文, 日浅, 雅博, イワサ, マサミ, 原田, 武志, 藤井, 志朗, 曽我部, 公子, 賀川, 久美子, 吉田, 守美子, 遠藤, 逸朗, 粟飯原, 賢一, 安倍, 正博Impact Journals2016-10-12Oncotarget7 48p.79064-79075
Available onlineOther Libraries in Japan
  • Summary, etc....ation with the proteasome inhibitor bortezomib. Be......synergism with proteasome inhibitors. Although the......nobinostat and proteasome inhibitors in combination.
  • Subject Headingmultiple myeloma panobinostat proteasome inhibitors caspase-8 Sp1

Unique anti-myeloma activity by thiazolidine-2,4-dione compounds with Pim inhibiting activity

Unique anti-myeloma activity by thiazolidine-2,4-dione compounds with Pim inhibiting activity
Digital博士論文
藤井, 志朗, 中村, 信元, オダ, アスカ, 三木, 浩和, 天眞, 寛文, 寺町, 順平, 日浅, 雅博, Bat-Erdene, Ariunzaya, マエダ, ユウサク, 大浦, 雅博, タカハシ, マミコ, イワサ, マサミ, 遠藤, 逸朗, 吉田, 守美子, 粟飯原, 賢一, 倉橋, 清衛, 原田, 武志, 賀川, 久美子, 中尾, 允泰, 佐野, 茂樹, 安倍, 正博Wiley2018-01-12British Journal of Haematology180 2p.246-258
Available onlineOther Libraries in Japan
  • Summary, etc....sistently, the proteasome inhibitors bortezomib an......mbination with proteasome inhibitors is envisioned.
  • Subject Heading...stance protein proteasome inhibitor BCRP

Activating transcription factor 4, an ER stress mediator , is required for, but excessive ER stress suppresses osteoblastogenesis by bortezomib

Activating transcription factor 4, an ER stress mediator , is required for, but excessive ER stress suppresses osteoblastogenesis by bortezomib
Digital博士論文
中村, 信元, 三木, 浩和, キド, シンスケ, ナカノ, アヤコ, 日浅, 雅博, オダ, アスカ, アモウ, ヒロエ, 渡邉, 佳一郎, 原田, 武志, 藤井, 志朗, タケウチ, キョウコ, 賀川, 久美子, オザキ, シュウジ, 松本, 俊夫, 安倍, 正博The Japanese Society of Hematology2013-05-25International Journal of Hematology98 1p.66-73
Available onlineOther Libraries in Japan
  • Subject HeadingMyeloma ER stress Bortezomib Proteasome inhibitor Activating transcription fact...

Reached to the end of result.

RSS